ResearcherFirst Affiliated Hospital of Jiamusi UniversityNo recent work listed
Kai Cheng
Matched on ORCID iD 0000-0002-3858-0798; OpenAlex author ID A5100437963.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 2, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 1
2019: 1 paper · 2020: none · 2021: 1 paper
Papers 2
- MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1 [Retraction]. First author DOI 10.2147/ott.s341749↗
- MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1. First author DOI 10.2147/ott.s218876↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Nannan Chi · 2 shared papers, 2019–2021
- Paper MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Prot… DOI 10.2147/ott.s341749↗
- Paper MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Prot… DOI 10.2147/ott.s218876↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.